The Campaign for Sustainable Rx Pricing, of which the AHA is a founding member, today joined more than a dozen other health organizations in urging the Food and Drug Administration to finalize guidance critical to increasing competition in the biologics marketplace and expanding access to more affordable biosimilar options, similar to the generic options that exist today for molecule drugs. While a small population of patients use biologic drugs, they account for more than 40 percent of prescription drug spending – in large part because of additional regulatory hurdles that discourage developers from introducing biosimilars. The groups said that guidance would improve FDA's approval of lower cost options for the patients who rely on costly biologic drugs – a focus of the FDA’s Biosimilars Action Plan, which was introduced last month as one of the Administration’s efforts to address out-of-control drug prices. “We are very hopeful that this guidance will increase access to affordable biological products and strongly urge the FDA to finalize it as soon as possible,” the groups wrote.

Related News Articles

Headline
The Centers for Disease Control and Prevention has partnered with Medscape to offer free online training on its recommendations for vaccinating homeless people…
Blog
In this AHA Stat Blog, Priya Bathija, vice president of AHA’s The Value Initiative, discusses manageable ways hospitals and health systems can become consumer-…
Headline
The National Institutes of Health’s All of Us Research Program today awarded a health technology company $4.6 million in initial funding to provide genetic…
Insights and Analysis
An invisible beam that detects ships and airplanes. An innovative drug that reduces cholesterol in a way no one has tried. The notion that tumors can be killed…
Headline
The departments of Health and Human Services and the Treasury Friday approved a Section 1332 waiver for Montana to implement a five-year reinsurance program…
Headline
Thirteen states yesterday filed a lawsuit challenging a Department of Homeland Security final rule limiting the ability of legal immigrants to adjust or extend…